Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00741117 · ClinicalTrials.gov registry record · NA
Conjugated Hyperbilirubinemia and Pulse Oximetry
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00741117 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 4 participants.
The verdict
NCT00741117, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if higher levels of bilirubin in the blood of people with liver disease affects how accurate a pulse oximeter machine is able to measure the concentration of oxygen in the blood. Previous studies have reported conflicting results regarding the affect of high levels of bilirubin in the blood on the accuracy of the pulse oximeter reading. Initial studies showed an underestimation of the oxygen concentration in the presence of elevated bilirubin. Subsequent studies have suggested that high levels of bilirubin in the blood do not influence the accuracy of the pulse oximeter machine. However, recent reports in bone marrow transplant literature and our personal observations in patients with liver disease suggest that high bilirubin levels are associated with an overestimation of the oxygen concentration as measured by the pulse oximeter machine.
Interventions
- PROCEDURE Arterial Blood Gas
- PROCEDURE Pulse Oximetry Machine
- PROCEDURE Direct and Indirect Serum Bilirubin Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-10 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00741117
The ClinicalTrials.gov registry entry for NCT00741117 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Arterial Blood Gas is the first listed.
NCT00741117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00741117 about?
NCT00741117 is a clinical study titled "Conjugated Hyperbilirubinemia and Pulse Oximetry". The purpose of this study is to determine if higher levels of bilirubin in the blood of people with liver disease affects how accurate a pulse oximeter machine is able to measure the concentration of oxygen in the blood. Previous studies have reported conflicting results regarding the affect of high...
What is the current status of trial NCT00741117?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2011-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00741117?
The interventions under investigation include: Arterial Blood Gas (PROCEDURE), Pulse Oximetry Machine (PROCEDURE), Direct and Indirect Serum Bilirubin Measurement (PROCEDURE).
Who is sponsoring clinical trial NCT00741117?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.